Vineti Stock

vineti.comHealthcare / Healthcare softwareFounded: 2016Funding to Date: $107.72MM

Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies. This company was founded by Razmik Abnous, Amy DuRoss, Malek Faham, Heidi Hagen, Stephen Ting in 2016 and is headquartered in San Francisco, CA. Vineti's software solution Personalized Therapy Management (patent pending) automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Vineti, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Vineti’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Vineti.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Joe DePinto
Chief Commercial Officer
Brett Robertson
Chief Financial Officer
Amy DuRoss
Co-Founder & Chief Executive Officer
Phil Calvin
Chief Technology Officer
Subbu Viswanathan
Compliance Officer & SVP, Quality, Security & Compliance
Louise Rose Pacini
Chief Operations Officer
Heidi M. Hagen
Co-Founder

Board Members

Eli Casdin
Casdin Capital
Neil Kurtz
Medidata
Michael Pellini
Section 32
John kontor
Optum
Nina Kjellson
Canaan Partners
Michele Holcomb
Cardinal Health
Emily Melton
Threshold Ventures

Vineti’s stock FAQs

plusminus

Can you buy Vineti’s stock?

As Vineti is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Vineti, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge's Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Vineti’s stock?

To invest in a private company like Vineti’s through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge's marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Vineti’s stock?

Yes, you may be able to sell your Vineti’s stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Vineti’s stock?

If you hold private company shares of Vineti’s - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Vineti’s on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Vineti’s a public company?

No, Vineti’s is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Vineti’s stock price?

Vineti is a privately held company and therefore does not have a public stock price. However, you may access Vineti’s private market stock price with Forge Data.
plusminus

What is Vineti’s stock ticker symbol?

Vineti does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Vineti announces agreement with Imvax to utilize Vineti's PTM Essentials™ solution

Vineti’s enterprise technology will enable critical patient-specific Chain of Custody management for Imvax, supporting Imvax’s goal of reaching more...

Drugmakers flock to Vineti's fix for a cell, gene therapy problem

A coalition of drugmakers has agreed to work with Vineti, a San Francisco-based technology company, to usher in new standards that could ease some of the safety and logistic concerns surrounding advanced medicines like cell and gene therapies.

Vineti Extends Series C Funding Round to $68M with an Expanded Investor Coalition

This $33 million extension to Vineti’s Series C in February 2020 will be used to further grow the company’s leading enterprise platform for advanced...
Updated on: Jul 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.